Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 45

References for PMC Articles for PubMed (Select 23154638)

1.

Deubiquitinating enzyme A20 negatively regulates NF-κB signaling in skeletal muscle in mdx mice.

Charan RA, Hanson R, Clemens PR.

FASEB J. 2012 Feb;26(2):587-95. doi: 10.1096/fj.11-189829. Epub 2011 Oct 19. Erratum in: FASEB J. 2013 Jan;27(1):410.

2.

Activation of NF-kappaB pathway in Duchenne muscular dystrophy: relation to age.

Messina S, Vita GL, Aguennouz M, Sframeli M, Romeo S, Rodolico C, Vita G.

Acta Myol. 2011 Jun;30(1):16-23.

3.

The soy isoflavone genistein blunts nuclear factor kappa-B, MAPKs and TNF-α activation and ameliorates muscle function and morphology in mdx mice.

Messina S, Bitto A, Aguennouz M, Vita GL, Polito F, Irrera N, Altavilla D, Marini H, Migliorato A, Squadrito F, Vita G.

Neuromuscul Disord. 2011 Aug;21(8):579-89. doi: 10.1016/j.nmd.2011.04.014. Epub 2011 Jun 11.

PMID:
21658942
4.

Systemic delivery of NEMO binding domain/IKKγ inhibitory peptide to young mdx mice improves dystrophic skeletal muscle histopathology.

Reay DP, Yang M, Watchko JF, Daood M, O'Day TL, Rehman KK, Guttridge DC, Robbins PD, Clemens PR.

Neurobiol Dis. 2011 Sep;43(3):598-608. doi: 10.1016/j.nbd.2011.05.008. Epub 2011 May 23.

5.

Rapamycin ameliorates dystrophic phenotype in mdx mouse skeletal muscle.

Eghtesad S, Jhunjhunwala S, Little SR, Clemens PR.

Mol Med. 2011 Sep-Oct;17(9-10):917-24. doi: 10.2119/molmed.2010.00256. Epub 2011 May 20.

6.

Activation of the NF-kappaB pathway by adeno-associated virus (AAV) vectors and its implications in immune response and gene therapy.

Jayandharan GR, Aslanidi G, Martino AT, Jahn SC, Perrin GQ, Herzog RW, Srivastava A.

Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3743-8. doi: 10.1073/pnas.1012753108. Epub 2011 Feb 14.

7.

Inhibition of the IKK/NF-κB pathway by AAV gene transfer improves muscle regeneration in older mdx mice.

Tang Y, Reay DP, Salay MN, Mi MY, Clemens PR, Guttridge DC, Robbins PD, Huard J, Wang B.

Gene Ther. 2010 Dec;17(12):1476-83. doi: 10.1038/gt.2010.110. Epub 2010 Aug 19.

8.

Frequency and spectrum of genomic integration of recombinant adeno-associated virus serotype 8 vector in neonatal mouse liver.

Inagaki K, Piao C, Kotchey NM, Wu X, Nakai H.

J Virol. 2008 Oct;82(19):9513-24. doi: 10.1128/JVI.01001-08. Epub 2008 Jul 9.

9.

Construction and analysis of compact muscle-specific promoters for AAV vectors.

Wang B, Li J, Fu FH, Chen C, Zhu X, Zhou L, Jiang X, Xiao X.

Gene Ther. 2008 Nov;15(22):1489-99. doi: 10.1038/gt.2008.104. Epub 2008 Jun 19.

PMID:
18563184
10.

Curcumin alleviates dystrophic muscle pathology in mdx mice.

Pan Y, Chen C, Shen Y, Zhu CH, Wang G, Wang XC, Chen HQ, Zhu MS.

Mol Cells. 2008 Jun 30;25(4):531-7. Epub 2008 May 6.

11.

L-arginine decreases inflammation and modulates the nuclear factor-kappaB/matrix metalloproteinase cascade in mdx muscle fibers.

Hnia K, Gayraud J, Hugon G, Ramonatxo M, De La Porte S, Matecki S, Mornet D.

Am J Pathol. 2008 Jun;172(6):1509-19. doi: 10.2353/ajpath.2008.071009. Epub 2008 May 5.

12.

IKK/NF-kappaB regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis.

Bakkar N, Wang J, Ladner KJ, Wang H, Dahlman JM, Carathers M, Acharyya S, Rudnicki MA, Hollenbach AD, Guttridge DC.

J Cell Biol. 2008 Feb 25;180(4):787-802. doi: 10.1083/jcb.200707179.

13.

NF-kappaB signaling in skeletal muscle: prospects for intervention in muscle diseases.

Mourkioti F, Rosenthal N.

J Mol Med (Berl). 2008 Jul;86(7):747-59. doi: 10.1007/s00109-008-0308-4. Epub 2008 Feb 2. Review.

14.

Molecular basis for the unique deubiquitinating activity of the NF-kappaB inhibitor A20.

Lin SC, Chung JY, Lamothe B, Rajashankar K, Lu M, Lo YC, Lam AY, Darnay BG, Wu H.

J Mol Biol. 2008 Feb 15;376(2):526-40. doi: 10.1016/j.jmb.2007.11.092. Epub 2007 Dec 4.

15.

Nuclear factor-kappaB activation: from bench to bedside.

Sethi G, Sung B, Aggarwal BB.

Exp Biol Med (Maywood). 2008 Jan;233(1):21-31. Review.

PMID:
18156302
16.
17.

Ubiquitination, phosphorylation, and acetylation--triple threat in muscle wasting.

Hasselgren PO.

J Cell Physiol. 2007 Dec;213(3):679-89. Review.

PMID:
17657723
18.

Role of tumour necrosis factor alpha, but not of cyclo-oxygenase-2-derived eicosanoids, on functional and morphological indices of dystrophic progression in mdx mice: a pharmacological approach.

Pierno S, Nico B, Burdi R, Liantonio A, Didonna MP, Cippone V, Fraysse B, Rolland JF, Mangieri D, Andreetta F, Ferro P, Camerino C, Zallone A, Confalonieri P, De Luca A.

Neuropathol Appl Neurobiol. 2007 Jun;33(3):344-59.

PMID:
17493014
19.

Pathophysiology of duchenne muscular dystrophy: current hypotheses.

Deconinck N, Dan B.

Pediatr Neurol. 2007 Jan;36(1):1-7. Review.

PMID:
17162189
20.

Dystrophin, its interactions with other proteins, and implications for muscular dystrophy.

Ervasti JM.

Biochim Biophys Acta. 2007 Feb;1772(2):108-17. Epub 2006 Jun 7. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk